Location History:
- Kobe, JP (2006)
- Osaka, JP (2010 - 2022)
Company Filing History:
Years Active: 2006-2022
Title: The Innovative Contributions of Masakuni Kori in Pharmaceutical Patents
Introduction
Masakuni Kori, an accomplished inventor based in Osaka, Japan, has made significant strides in the field of pharmaceutical innovation. With an impressive portfolio featuring 14 patents, Kori has contributed to advancements that could play a crucial role in treating various mental health conditions. His work primarily revolves around the discovery and application of heterocyclic compounds with therapeutic properties.
Latest Patents
Among his latest patents, Kori has developed a novel heterocyclic compound that exhibits an AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor potentiating action. This compound is pivotal as it holds potential for use as a prophylactic or therapeutic drug targeting conditions such as depression, schizophrenia, Alzheimer's disease, and attention deficit hyperactivity disorder (ADHD). The specificity of the compound highlights Kori’s commitment to addressing critical health challenges through innovative chemical solutions.
Career Highlights
Currently, Masakuni Kori is associated with Takeda Pharmaceutical Company Limited, where he continues to explore and refine his inventions. His career has been marked by a dedication to enhancing drug efficacy and development processes, making a lasting impact on the pharmaceutical landscape. Through strategic innovation, Kori has positioned himself as a leader in his field.
Collaborations
Masakuni Kori is known for his collaborations with esteemed colleagues such as Toshihiro Imaeda and Shinji Nakamura. Together, they have worked on various projects aimed at discovering and developing novel therapeutic compounds, fostering an environment of innovative thought and shared expertise within Takeda Pharmaceutical Company Limited.
Conclusion
In conclusion, Masakuni Kori represents a vital force in the realm of pharmaceutical inventions. His latest patents reflect a deep understanding of complex biological systems and a commitment to finding solutions for serious mental health issues. As he continues his work, Kori's contributions are expected to pave the way for new therapeutic approaches that could improve the lives of many individuals affected by these conditions.